-
1
-
-
0021259505
-
Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration
-
Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 323: 1311-5.
-
(1984)
Lancet
, vol.323
, pp. 1311-1315
-
-
Marshall, B.J.1
Warren, J.R.2
-
2
-
-
34247844165
-
Current concepts in the management of Helicobacter pylori infection: The Maastricht III Consensus Report
-
DOI 10.1136/gut.2006.101634
-
Malfertheiner P, Megraud F, O'Morain C, et al. The European Helicobacter Study Group (EHSG) Current concept in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781. (Pubitemid 46854190)
-
(2007)
Gut
, vol.56
, Issue.6
, pp. 772-781
-
-
Malfertheiner, P.1
Megraud, F.2
O'Morain, C.3
Bazzoli, F.4
El-Omar, E.5
Graham, D.6
Hunt, R.7
Rokkas, T.8
Vakil, N.9
Kuipers, E.J.10
-
3
-
-
70350641941
-
Grupa Robocza PTG-E do spraw zakażenia Helicobacter pylori. Ustalenia Grupy Roboczej PTGE dotycza̧ce postȩpowania w zakażeniu Helicobacter pylori -consensus 2008
-
Dzieniszewski J, Jarosz M; Grupa Robocza PTG-E do spraw zakażenia Helicobacter pylori. Ustalenia Grupy Roboczej PTGE dotycza̧ce postȩpowania w zakażeniu Helicobacter pylori -consensus 2008. Gastroenterol Pol 2008; 15: 323-31.
-
(2008)
Gastroenterol Pol
, vol.15
, pp. 323-331
-
-
Dzieniszewski, J.1
Jarosz, M.2
-
4
-
-
73849138182
-
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability
-
Luther J, Higgins PD, Schoenfeld PS, et al. Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: systematic review and meta-analysis of efficacy and tolerability. Am J Gastroenterol 2010; 105: 65-73.
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 65-73
-
-
Luther, J.1
Higgins, P.D.2
Schoenfeld, P.S.3
-
5
-
-
0035123052
-
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate
-
DOI 10.1046/j.1365-2036.2001.00931.x
-
Fakheri H, Malekzadeh R, Merat S, et al. Clarithromycin vs. furazolidone in quadruple therapy regiment for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001; 15: 411-6. (Pubitemid 32192865)
-
(2001)
Alimentary Pharmacology and Therapeutics
, vol.15
, Issue.3
, pp. 411-416
-
-
Fakheri, H.1
Malekzadeh, R.2
Merat, S.3
Khatibian, M.4
Fazel, A.5
Alizadeh, B.Z.6
Massarrat, S.7
-
6
-
-
4344592305
-
H. pylori antibiotic resistance: Prevalence, importance and advances in testing
-
Megraud F. H. pylori antibiotic resistance: prevalence, importance and advances in testing. Gut 2004; 53: 1374-84.
-
(2004)
Gut
, vol.53
, pp. 1374-1384
-
-
Megraud, F.1
-
7
-
-
24044443871
-
Antimicrobial resistance of Helicobacter pylori in Poland: A multicentre study
-
DOI 10.1016/j.ijantimicag.2005.06.015, PII S0924857905001780
-
Dzierżanowska-Fangrat K, Rożynek E, Celińska-Cedro D, et al. Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study. Int J Antimicrob Agents 2005; 26: 230-4. (Pubitemid 41219609)
-
(2005)
International Journal of Antimicrobial Agents
, vol.26
, Issue.3
, pp. 230-234
-
-
Dzierzanowska-Fangrat, K.1
Rozynek, E.2
Celinska-Cedro, D.3
Jarosz, M.4
Pawlowska, J.5
Szadkowski, A.6
Budzynska, A.7
Nowak, J.8
Romanczuk, W.9
Prosiecki, R.10
Jozwiak, P.11
Dzierzanowska, D.12
-
8
-
-
35449004823
-
Correlation between substitutions in penicillin-binding protein 1 and amoxicillin resistance in Helicobacter pylori
-
Rimbara E, Noguchi N, Kawai T, Sasatsu M. Correlation between substitutions in penicillin binding protein 1 and amoxicillin resistance in Helicobacter pylori. Microbiol Inmunol 2007; 51: 939-44. (Pubitemid 47623407)
-
(2007)
Microbiology and Immunology
, vol.51
, Issue.10
, pp. 939-944
-
-
Rimbara, E.1
Noguchi, N.2
Kawai, T.3
Sasatsu, M.4
-
9
-
-
64649086513
-
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard therapy: A randomized controlled trail
-
Kuo CH, Hu HM, Kuo FC, et al. Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard therapy: a randomized controlled trail. J Antimicrob Chemother 2009; 63: 1017-24.
-
(2009)
J Antimicrob Chemother
, vol.63
, pp. 1017-1024
-
-
Kuo, C.H.1
Hu, H.M.2
Kuo, F.C.3
-
10
-
-
37849047500
-
Second line rescue therapy with levofloxacin after H. pylori treatment failure: A Spanish multicenter study of 300 Patients
-
Gisbert JP, Bermejo F, Castro-Fernandez M, et al. Second line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 Patients. Am J Gastroenterol 2008; 103: 71-6.
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 71-76
-
-
Gisbert, J.P.1
Bermejo, F.2
Castro-Fernandez, M.3
-
11
-
-
67349145247
-
Second-line levofloxacin- based triple schemes for Helicobacter pylori eradication
-
di Caro S, Franceschi F, Mariani A, et al. Second-line levofloxacin- based triple schemes for Helicobacter pylori eradication. Dig Liver Dis 2009; 41: 480-5.
-
(2009)
Dig Liver Dis
, vol.41
, pp. 480-485
-
-
Di Caro, S.1
Franceschi, F.2
Mariani, A.3
-
12
-
-
33644925601
-
Systematic review and meta-analysis: Levofloxacin-based rescue regimens after Helicobacter pylori treatment failure
-
DOI 10.1111/j.1365-2036.2006.02737.x
-
Gisbert JP, Morena F. Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure. Aliment Pharmacol Ther 2006; 23: 35-44. (Pubitemid 43381164)
-
(2006)
Alimentary Pharmacology and Therapeutics
, vol.23
, Issue.1
, pp. 35-44
-
-
Gisbert, J.P.1
De La, M.F.2
-
13
-
-
77950841072
-
Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days moxifloxacin based therapy for the eradication: A randomized controlled trial
-
Bago J, Majstorović K, Belošić-Halle Z, et al. Antimicrobial resistance of H. pylori to the outcome of 10-days vs. 7-days moxifloxacin based therapy for the eradication: a randomized controlled trial. Ann Clin Microbiol Antimicrob 2010; 9: 13.
-
(2010)
Ann Clin Microbiol Antimicrob
, vol.9
, pp. 13
-
-
Bago, J.1
Majstorović, K.2
Belošić-Halle, Z.3
-
14
-
-
73749088673
-
Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment
-
Sacco F, Spezzaferro M, Amitrano M, et al. Efficacy of four different moxifloxacin-based triple therapies for first-line H. pylori treatment. Dig Liver Dis 2010; 42: 110-4.
-
(2010)
Dig Liver Dis
, vol.42
, pp. 110-114
-
-
Sacco, F.1
Spezzaferro, M.2
Amitrano, M.3
-
15
-
-
38149058786
-
One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin
-
Miehlke S, Schneider-Brachert W, Kirsch C, et al. One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin. Helicobacter 2008; 13: 69-74.
-
(2008)
Helicobacter
, vol.13
, pp. 69-74
-
-
Miehlke, S.1
Schneider-Brachert, W.2
Kirsch, C.3
-
16
-
-
33745877144
-
Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication
-
DOI 10.1111/j.1523-5378.2006.00416.x
-
Sharara AI, Chaar HF, Aoun E, et al. Efficacy and safety of rabeprazole, amoxicillin, and gatifloxacin after treatment failure of initial Helicobacter pylori eradication. Helicobacter 2006; 11: 231-6. (Pubitemid 44051348)
-
(2006)
Helicobacter
, vol.11
, Issue.4
, pp. 231-236
-
-
Sharara, A.I.1
Chaar, H.F.2
Aoun, E.3
Abdul-Baki, H.4
Araj, G.F.5
Kanj, S.S.6
-
17
-
-
57449094600
-
Gatifloxacin-based triple therapy as third-line regimen for Helicobacter pylori eradication
-
Nishizawa T, Suzuki H, Nakagawa I, et al. Gatifloxacin-based triple therapy as third-line regimen for Helicobacter pylori eradication. J Gastroenterol Hepatol 2008; 23: 167-70.
-
(2008)
J Gastroenterol Hepatol
, vol.23
, pp. 167-170
-
-
Nishizawa, T.1
Suzuki, H.2
Nakagawa, I.3
-
18
-
-
84861723085
-
Comparison of triple rabeprazole/metronidazol/sitafloxacin therapy with triple rabeprazole/ amoxicillin/sitafloxacin therapy as the third rescue regimen for eradication of H. pylori
-
Furuta T, Sugimoto M, Codaira C, et al. Comparison of triple rabeprazole/metronidazol/sitafloxacin therapy with triple rabeprazole/ amoxicillin/sitafloxacin therapy as the third rescue regimen for eradication of H. pylori. Helicobacter 2010; 14: 28.
-
(2010)
Helicobacter
, vol.14
, pp. 28
-
-
Furuta, T.1
Sugimoto, M.2
Codaira, C.3
-
19
-
-
0345306185
-
In Vitro and In Vivo Antibacterial Activities of DK-507k, a Novel Fluoroquinolone
-
DOI 10.1128/AAC.47.12.3750-3759.2003
-
Otani T, Tanaka M, Ito E, et al. In vitro and in vivo antibacterial activities of DK-507k, a novel fluoroquinolone. Antimicrob Agents Chemother 2003; 47: 3750-9. (Pubitemid 37484983)
-
(2003)
Antimicrobial Agents and Chemotherapy
, vol.47
, Issue.12
, pp. 3750-3759
-
-
Otani, T.1
Tanaka, M.2
Ito, E.3
Kurosaka, Y.4
Murakami, Y.5
Onodera, K.6
Akasaka, T.7
Sato, K.8
-
20
-
-
36549063070
-
The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice
-
DOI 10.1111/j.1365-2036.2007.03531.x
-
van der Poorten D, Katelaris PH. The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice. Aliment Pharmacol Ther 2007; 26: 1537-42. (Pubitemid 350178803)
-
(2007)
Alimentary Pharmacology and Therapeutics
, vol.26
, Issue.11-12
, pp. 1537-1542
-
-
Van Der, P.D.1
Katelaris, P.H.2
-
21
-
-
2142751121
-
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts
-
DOI 10.1016/S1590-8658(03)00268-8, PII S1590865803002688
-
Parente F, Cucino C, Bianchi-Porro G, et al. Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. Dig Liver Dis 2003; 35: 523-8. (Pubitemid 41070406)
-
(2003)
Digestive and Liver Disease
, vol.35
, Issue.8
, pp. 523-528
-
-
Parente, F.1
Cucino, C.2
Bianchi, P.G.3
-
22
-
-
33750435590
-
Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures
-
DOI 10.1111/j.1365-2036.2006.03149.x
-
Gisbert JP, Gisbert JL, Marcos S, et al. Third-line rescue therapy with levofloxacin is more effective than rifabutin rescue regimen after two Helicobacter pylori treatment failures. Aliment Pharmacol Ther 2006; 24: 1469-74. (Pubitemid 44657124)
-
(2006)
Alimentary Pharmacology and Therapeutics
, vol.24
, Issue.10
, pp. 1469-1474
-
-
Gisbert, J.P.1
Gisbert, J.L.2
Marcos, S.3
Moreno-Otero, R.4
Pajares, J.M.5
-
23
-
-
38149041576
-
Empirical rescue therapy after Helicobacter pylori treatment failure: A 10-year single-centre study of 500 patients
-
Gisbert JP, Gisbert JL, Marcos S, et al. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients. Aliment Pharmacol Ther 2008; 27: 346-54.
-
(2008)
Aliment Pharmacol Ther
, vol.27
, pp. 346-354
-
-
Gisbert, J.P.1
Gisbert, J.L.2
Marcos, S.3
-
24
-
-
34247578074
-
Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease
-
Khatibian M, Ajvadi Y, Nasseri-Moghaddam S, et al. Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease. Arch Iranian Med 2007; 10: 161-7. (Pubitemid 46672405)
-
(2007)
Archives of Iranian Medicine
, vol.10
, Issue.2
, pp. 161-167
-
-
Khatibian, M.1
Ajvadi, Y.2
Nasseri-Moghaddam, S.3
Ebrahimi-Dariani, N.4
Vahedi, H.5
Zendehdel, N.6
Sotoudehmanesh, R.7
Agah, S.8
Mikaeli, J.9
Pourshams, A.10
Ali-Asgari, A.11
Malekzadeh, R.12
Massarrat, S.13
-
25
-
-
0035123052
-
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate
-
DOI 10.1046/j.1365-2036.2001.00931.x
-
Fakheri H, Malekzadeh R, Merat S. Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001; 15: 411-6. (Pubitemid 32192865)
-
(2001)
Alimentary Pharmacology and Therapeutics
, vol.15
, Issue.3
, pp. 411-416
-
-
Fakheri, H.1
Malekzadeh, R.2
Merat, S.3
Khatibian, M.4
Fazel, A.5
Alizadeh, B.Z.6
Massarrat, S.7
-
26
-
-
0034129259
-
A new highly effective shout-term therapy schedule for Helicobacter pylori eradication
-
DOI 10.1046/j.1365-2036.2000.00766.x
-
Zullo A, Rinaldi V, Winn S, et al. A new highly effective shortterm therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000; 14: 715-8. (Pubitemid 30352737)
-
(2000)
Alimentary Pharmacology and Therapeutics
, vol.14
, Issue.6
, pp. 715-718
-
-
Zullo, A.1
Rinaldi, V.2
Winn, S.3
Meddi, P.4
Lionetti, R.5
Hassan, C.6
Ripani, C.7
Tomaselli, G.8
Attili, A.F.9
-
27
-
-
34948911342
-
The sequential therapy regimen for Helicobacter pylori eradication: A pooled-data analysis
-
DOI 10.1136/gut.2007.125658
-
Zullo A, de Francesco V, Hassan C, et al. The sequential therapy regimen for Helicobacter pylori eradication. Gut 2007; 56: 1353-7. (Pubitemid 47517826)
-
(2007)
Gut
, vol.56
, Issue.10
, pp. 1353-1357
-
-
Zullo, A.1
De Francesco, V.2
Hassan, C.3
Morini, S.4
Vaira, D.5
-
28
-
-
0036161402
-
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy
-
DOI 10.1016/S0924-8579(01)00456-3, PII S0924857901004563
-
Murakami K, Fujioka T, Okimoto T, et al. Drug combinations with amoxicillin reduces selection of clarithromycin resistance during Helicobacter pylori eradication therapy. Int J Antimicrob Agents 2002; 19: 67-70. (Pubitemid 34119073)
-
(2002)
International Journal of Antimicrobial Agents
, vol.19
, Issue.1
, pp. 67-70
-
-
Murakami, K.1
Fujioka, T.2
Okimoto, T.3
Sato, R.4
Kodama, M.5
Nasu, M.6
-
29
-
-
77949933512
-
Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: A randomized controlled study on efficacy and tolerability
-
Paoluzi OA, Visconti E, Andrei F, et al. Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability. J Clin Gastroenterol 2010; 44: 261-6.
-
(2010)
J Clin Gastroenterol
, vol.44
, pp. 261-266
-
-
Paoluzi, O.A.1
Visconti, E.2
Andrei, F.3
-
30
-
-
72949096113
-
Sequential therapy or triple therapy for Helicobacter pylori infection: Systemic review and meta-analysis of randomized controlled trials in adults and children
-
Gatta L, Vakil N, Leandro G, et al. Sequential therapy or triple therapy for Helicobacter pylori infection: systemic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol 2009; 104: 3069-79.
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 3069-3079
-
-
Gatta, L.1
Vakil, N.2
Leandro, G.3
-
31
-
-
78049503288
-
Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomised trial
-
Romano M, Cuomo A, Gravina AG, et al. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010; 59: 1465-70.
-
(2010)
Gut
, vol.59
, pp. 1465-1470
-
-
Romano, M.1
Cuomo, A.2
Gravina, A.G.3
-
32
-
-
77949885213
-
Sequential therapy for Helicobacter pylori eradication: The time is now!
-
Vaira D, Zullo A, Hassan C, et al. Sequential therapy for Helicobacter pylori eradication: the time is now! Therap Adv Gastroenterol 2009; 2: 317-22.
-
(2009)
Therap Adv Gastroenterol
, vol.2
, pp. 317-322
-
-
Vaira, D.1
Zullo, A.2
Hassan, C.3
-
33
-
-
27744501086
-
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: A randomized trial
-
Francavilla R, Lionetti E, Castellaneta SP, et al. Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial. Gastroenterology 2005; 129: 1414-5.
-
(2005)
Gastroenterology
, vol.129
, pp. 1414-1415
-
-
Francavilla, R.1
Lionetti, E.2
Castellaneta, S.P.3
-
34
-
-
33644798246
-
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori
-
de Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006; 144: 94-100.
-
(2006)
Ann Intern Med
, vol.144
, pp. 94-100
-
-
De Francesco, V.1
Margiotta, M.2
Zullo, A.3
-
35
-
-
3543058738
-
Towards the ideal regimen for Helicobacter pylori eradication: The search continues
-
DOI 10.1016/j.dld.2004.01.004
-
Scarpignato C. Towards the ideal regimen for Helicobacter pylori eradication: the search continues. Dig Liver Dis 2004; 36: 243-7. (Pubitemid 41115471)
-
(2004)
Digestive and Liver Disease
, vol.36
, Issue.4
, pp. 243-247
-
-
Scarpignato, C.1
-
36
-
-
64549123418
-
Kliniczne znaczenie polimorfizmu wybranych genów cytochromu P-450 rodziny CYP1, podrodziny CYP2A, CYP2B oraz CYP2C
-
Wojtczak A, Skrȩtkowicz J. Kliniczne znaczenie polimorfizmu wybranych genów cytochromu P-450 rodziny CYP1, podrodziny CYP2A, CYP2B oraz CYP2C. Pol Merk Lek 2009; 153: 248-52.
-
(2009)
Pol Merk Lek
, vol.153
, pp. 248-252
-
-
Wojtczak, A.1
Skrȩtkowicz, J.2
-
37
-
-
33846695464
-
Postçpowanie w przypadku nieskutecznego leczenia eradykacyjnego Helicobacter pylori
-
Annabhani A, Paradowski L, Sajewicz Z, et al. Management in patients with Helicobacter pylori eradication failure. Adv Clin Exp Med 2006; 15: 1087-92. (Pubitemid 46195541)
-
(2006)
Advances in Clinical and Experimental Medicine
, vol.15
, Issue.6
, pp. 1087-1092
-
-
Annabhani, A.1
Paradowski, L.2
Sajewicz, Z.3
Ewa, W.4
-
38
-
-
34247862031
-
Helicobacter pylori eradication: A randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics
-
DOI 10.1111/j.1572-0241.2007.01085.x
-
de Bortoli N, Leonardi G, Ciancia E, et al. Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics. Am J Gastroenterol 2007; 102: 951-6. (Pubitemid 46698221)
-
(2007)
American Journal of Gastroenterology
, vol.102
, Issue.5
, pp. 951-956
-
-
De Bortoli, N.1
Leonardi, G.2
Ciancia, E.3
Merlo, A.4
Bellini, M.5
Costa, F.6
Mumolo, M.G.7
Ricchiuti, A.8
Cristiani, F.9
Santi, S.10
Rossi, M.11
Marchi, S.12
-
39
-
-
33646875068
-
Bovine lactoferrin for Helicobacter pylori eradication: An open, randomized, multicentre study
-
DOI 10.1111/j.1365-2036.2006.02851.x
-
di Mario F, Aragona G, Dal-Bo N, et al. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. Aliment Pharmacol Ther 2006; 23: 1235-40. (Pubitemid 43779364)
-
(2006)
Alimentary Pharmacology and Therapeutics
, vol.23
, Issue.8
, pp. 1235-1240
-
-
Di, M.F.1
Aragona, G.2
Dal, B.N.3
Cavallaro, L.4
Marcon, V.5
Olivieri, P.6
Benedetti, E.7
Orzes, N.8
Marin, R.9
Tafner, G.10
Chilovi, F.11
De Bastiani, R.12
Fedrizzi, F.13
Franceschi, M.14
Salvat, M.H.15
Monica, F.16
Piazzi, L.17
Valiante, F.18
Vecchiati, U.19
Cavestro, G.M.20
Comparato, G.21
Iori, V.22
Maino, M.23
Leandro, G.24
Pilotto, A.25
Rugge, M.26
Franze, A.27
more..
-
40
-
-
79952280839
-
Citric acid inhibits growth of Helicobacter pylori in vitro: A new strategy for eradication
-
Zazgornik J, Mittermayer H. Citric acid inhibits growth of Helicobacter pylori in vitro: a new strategy for eradication. Wien Klin Wochenschr 2011; 123: 38-40.
-
(2011)
Wien Klin Wochenschr
, vol.123
, pp. 38-40
-
-
Zazgornik, J.1
Mittermayer, H.2
-
41
-
-
47949097028
-
Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds
-
Javad M, Siavoshi F, Emami S, et al. Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4- thiadiazol-2-yl]thiomorpholines and related compounds. Eur J Med Chem 2008; 43: 1575-80.
-
(2008)
Eur J Med Chem
, vol.43
, pp. 1575-1580
-
-
Javad, M.1
Siavoshi, F.2
Emami, S.3
-
42
-
-
44149108441
-
Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4- thiadiazoles with certain sulfur containing alkyl side chain
-
DOI 10.1016/j.bmcl.2008.04.033, PII S0960894X08004241
-
Foroumadi A, Rineh A, Emami S, et al. Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain. Bioorg Med Chem Lett 2008; 18: 3315-20. (Pubitemid 351718322)
-
(2008)
Bioorganic and Medicinal Chemistry Letters
, vol.18
, Issue.11
, pp. 3315-3320
-
-
Foroumadi, A.1
Rineh, A.2
Emami, S.3
Siavoshi, F.4
Massarrat, S.5
Safari, F.6
Rajabalian, S.7
Falahati, M.8
Lotfali, E.9
Shafiee, A.10
-
43
-
-
19944431182
-
Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives
-
DOI 10.1016/j.bmcl.2004.11.042, PII S0960894X04014003
-
Chimenti F, Bizzarri B, Manna F, et al. Synthesis and in vitro selective anti-Helicobacter pylori activity of pyrazoline derivatives. Bioorg Med Chem Lett 2005; 15: 603-7. (Pubitemid 40143132)
-
(2005)
Bioorganic and Medicinal Chemistry Letters
, vol.15
, Issue.3
, pp. 603-607
-
-
Chimenti, F.1
Bizzarri, B.2
Manna, F.3
Bolasco, A.4
Secci, D.5
Chimenti, P.6
Granese, A.7
Rivanera, D.8
Lilli, D.9
Scaltrito, M.M.10
Brenciaglia, M.I.11
-
44
-
-
77955425222
-
Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides
-
Chimenti F, Bizzarri B, Bolasco A, et al. Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. Bioorg Med Chem Lett 2010; 20: 4922-6.
-
(2010)
Bioorg Med Chem Lett
, vol.20
, pp. 4922-4926
-
-
Chimenti, F.1
Bizzarri, B.2
Bolasco, A.3
-
45
-
-
78650972161
-
Floating-bioadhesive microspheres of clarithromycin versus antibacterial agent caragenin CsA-13 for eradication of Helicobacter pylori resistant: Meta-analysis
-
Vaiciunas S, Oliveira MA, Bezerra IL, et al. Floating-bioadhesive microspheres of clarithromycin versus antibacterial agent caragenin CsA-13 for eradication of Helicobacter pylori resistant: meta-analysis. Gastroenterology 2010; 138: 339-40.
-
(2010)
Gastroenterology
, vol.138
, pp. 339-340
-
-
Vaiciunas, S.1
Oliveira, M.A.2
Bezerra, I.L.3
-
46
-
-
70349630154
-
Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice
-
Leszczyńska K, Namiot A, Fein DE, et al. Bactericidal activities of the cationic steroid CSA-13 and the cathelicidin peptide LL-37 against Helicobacter pylori in simulated gastric juice. BMC Microbiol 2009; 9: 187-9.
-
(2009)
BMC Microbiol
, vol.9
, pp. 187-189
-
-
Leszczyńska, K.1
Namiot, A.2
Fein, D.E.3
|